Archer-Daniels-Midland Company

Archer-Daniels-Midland Company’s 2025 10-K presents a notable structural choice in its Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A). This section, which typically provides a narrative overview of the company’s financial performance and condition, explicitly states that “Discussions of 2023 items and year-to-year comparisons between 2024 and 2023 are not included in this Form 10-K.” Instead, readers are directed to the prior year’s filing for this information, a decision that fragments the standard three-year comparative analysis.

The automated forensic scans, designed to identify potential accounting irregularities or financial distress, are not available for this filing. Beneish’s M-Score, a 1999 eight-ratio earnings-manipulation detector, would typically provide a numerical gauge of accounting quality. Similarly, Altman’s Z″, a 1968 bankruptcy-distress index, would offer insight into the company’s solvency. Piotroski’s F-Score, a 2000 9-point fundamental strength scan, would assess operational efficiency and financial leverage. The Fog Index, Gunning’s 1952 readability score, would indicate the complexity of the prose.

The MD&A’s decision to omit 2023 comparisons means that a comprehensive view of the company’s recent financial trajectory requires consulting two separate filings: the current 2025 10-K for 2025 and 2024 data, and the 2024 10-K, filed February 20, 2025, for 2024 and 2023 comparisons. This structural choice increases the friction for analysts and investors seeking a complete, contiguous financial narrative, potentially obscuring longer-term trends or shifts in performance that span more than two years.

Without the quantitative signals from Beneish’s M-Score, Altman’s Z″, Piotroski’s F-Score, or the Fog Index, this reading is limited to observations on the filing’s structure rather than its underlying financial health or readability. The absence of these scores means the “fairly-valued” accent is a default classification, not an endorsement of fundamental strength or a clean bill of health from a forensic perspective. The filing itself, however, clearly outlines the scope of its comparative data. Read the 10-K. Decide for yourself.